Director William Rastetter Sells Shares of Neurocrine Biosciences Inc (NBIX)

On January 2, 2024, Director William Rastetter executed a sale of 11,044 shares of Neurocrine Biosciences Inc (NASDAQ:NBIX), according to a recent SEC Filing.

Related Keywords

,Neurocrine Biosciences Inc ,Gurufocus Value ,Biopharmaceutical Company ,William Rastetter ,Neurocrine Biosciences ,